Mehmet Ağar

Mehmet Ağar

Auto-generated profile, based on publicly available information

Mehmet Ağar

Private Clinic,Sanlıurfa, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2022 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
PDF file
NGNaziye Gurkan
Naziye Gurkan
MAMehmet Ağar
Mehmet Ağar
TGTuğba Gürbüz
Tuğba Gürbüz
Introduction: Polycystic ovary syndrome (PCOS) causes endocrine disorders that affect the functioning of the reproductive system and the body's metabolic system. Bowel movement disorders and abdominal pain are common complaints of PCOS patients. Few studies have been performed on the relationship between PCOS and irritable bowel syndrome (IBS), and the association between the two syndromes is unclear. Material and Method: In the study, 72 patients were enrolled at gynecology and obstetric clinic in Turkey. The control group were (n=34) and women with PCOS (n=38). IBS diagnosis was made by using Roma IV criteria. Results: The results showed that IBS prevalence was similar in PCOS (52%) and the control group (50%) (p>0.05). No statistically significant association was found between IBS-PCOS and non-IBS-PCOS in terms of gastrointestinal symptoms (p=0.685). These symptoms were associated with PCOS rather than IBS. Significant differences have been observed between IBS-PCOS and non-IBS-PCOS for fasting insulin (FI), luteinizing hormone (LH) and Homeostasis model assessment for insulin resistance (HOMA-IR) (p

28 April 2023 in Journal of Controversies in Obstetrics & Gynecology and Pediatrics
Verified
Journal Article
Open access
PDF file
MAMehmet Ağar
Mehmet Ağar
MÖMurat Önal
Murat Önal
AKAyşe Şeyma Küçükakça
Ayşe Şeyma Küçükakça
Aims: To examine the association between thyroid autoimmunity (TAI) and early pregnancy serum beta human chorionic gonadotropin (ß-hCG) levels in spontaneous pregnancy. Methods: In this retrospective case-control study, women between the ages of 20 and 40 were included. The study subjects were 130 women euthyroid and healthy patients with spontaneous pregnancy. Subjects were divided into two groups: those with autoimmune thyroid disease (TAI group; n=60) and those without the disease (control group; n=70). Results: The mean age and body mass index (BMI) of the subjects were 30.22±4.14 years and 24.51±2.04, respectively. The value of anti-thyroid peroxidase antibodies (TPO-Abs) and anti-thyroglobulin antibodies (TG-Abs) in the TAI group is three times twenty times more than the control, respectively. Results found no statistically significant association between between TAI and control groups in regard to hemoglobin, alanine transaminase (ALT), aspartate transaminase (AST), thyroid-stimulating hormone (TSH), platelet (PLT), creatine, free thyroxin (FT4), and blood urea nitrogen (BUN) (p>0.05). There was statistically significant difference between groups in terms of the serum ß-hCG level (p<0.05). Conclusion: In this study, the effects of TAI were significant on early-stage pregnancy serum ß-hCG levels; therefore, thyroid levels should be considered, and proper treatment should be started early.

22 October 2022 in Anatolian Current Medical Journal
Verified
Journal Article
Closed access
PDF file
MAMehmet Ağar
Mehmet Ağar
NGNaziye Gurkan
Naziye Gurkan
TGTuğba Gürbüz
Tuğba Gürbüz
Aim: In this study, the fertility rate of women with polycystic ovary syndrome (PCOS) and endometriosis was compared with the control group, which included women with normoresponder (NR) endometriosis. Material and Method: This is a retrospective study with control in infertile women aged 25-40, suffering from PCOS and endometriosis, referred to the infertility clinic of Medistate Hospital between September 2018- December 2020. The pregnancy outcomes of age-matched participants were compared. Results: Results did not show a statistically significant association between case and control regarding age and body mass index (BMI) (p>0.05). There was a statistically significant difference between groups regarding anti-mullerian hormone (AMH) (p0.05). Conclusion: Women with PCOS and endometriosis did not show a significant difference in terms of pregnancy outcome compared to women with NR women with endometriosis.

28 June 2022 in Journal of Medicine and Palliative Care
Verified
Journal Article
Closed access
PDF file
NGNaziye Gürkan
Naziye Gürkan
MAMehmet Ağar
Mehmet Ağar
EDErgul Demircivi
Ergul Demircivi
Aim: Menopause, the natural process of women’s aging, brings many problems. With menopause, the loss of mammary glandular tissue increases rapidly, and large losses occur in the mammary glands due to atrophy, degeneration, and hyalinization. Ultrasonography (USG) helps to detect these breast changes. This study compared breast USG findings in menopausal cases before and after 40 years. Material and Method: The files of menopausal patients who applied to the Gynecology and Obstetrics Clinic of Göztepe Prof. Dr. Süleyman Yalçın City Hospital between October 2014 and September 2020 were retrospectively scanned and analyzed. According to the age of patients entering menopause, it was divided into two groups: 1st group under 40 years old and 2nd group over 40 years old. 52 patients in the 1st group (case group) and 67 patients in the 2nd group (control group) were included in the study. Results: The mean age of the participants in the study was 33.2 in the 1st group and 48.6 in the 2nd group. Body mass indexes (BMI) were 24.8 kg/m² in group 1 and 25.1 kg/m² in group 2. When the breast USG findings were examined, the incidence of cyst formation in the 1st group was found to be statistically significantly higher than in the 2nd group (p

20 January 2023 in Anatolian Current Medical Journal
Verified
Journal Article
Open access
PDF file
MÖMurat Önal
Murat Önal
MAMehmet Ağar
Mehmet Ağar
AKAyşe Şeyma KÜÇÜKAKÇA
Ayşe Şeyma KÜÇÜKAKÇA
TGTuğba Gürbüz
Tuğba Gürbüz
Aim: This study aimed to evaluate the most suitable endometrial preparation protocols such as hormone replacement therapy (HRT) with gonadotropin releasing hormone analogue (GnRH-a) suppression, HRT without GnRH-a suppression and mild ovarian stimulation (OS) for women with polycystic ovary syndrome (PCOS) undergoing frozen-thawed embryo transfer (FET). Material and Method: We conducted a historical cohort analysis of 161 women with PCOS who underwent the “freeze-all” strategy between December 2018 and August 2020 because of their high risk for ovarian hyperstimulation syndrome. Three endometrial preparation protocols were used: HRT with GnRH-a suppression (n=43); HRT without GnRH-a suppression (n=86); mild-OS (n=32). Results: The biochemical pregnancy results (55.8 % vs 54.65 % vs 53, p=0.900), ongoing pregnancy rates (44.2 % vs 43 % vs 40.62, p=0.572), and abort rates (20.8 % vs 21.3 % vs 23.52, p=0.900) were similar between the HRT with GnRH-a suppression, without GnRH-a suppression and mild-OS, respectively. This study showed no statistically significant difference between the three protocols in laboratory parameters (p>0.05). Conclusion: There was no statistically difference between three groups in terms of pregnancy outcomes. Dependent on clinical experience and facility, one of these protocols could be deployed for FET in women with PCOS.

7 July 2025 in Journal of Controversies in Obstetrics & Gynecology and Pediatrics
Verified
Journal Article
Open access
PDF file
NUNurgül Ulusoy
Nurgül Ulusoy
MAMehmet Ağar
Mehmet Ağar
HÖHalime Çalı Öztürk
Halime Çalı Öztürk
Aims: Polycystic ovary syndrome (PCOS) is ssociated with an increased risk of metabolic syndrome (MetS) and cardiovascular diseases (CVD). This study aimed to evaluate the prevalence of MetS and cardiovascular risk factors in women with and without PCOS to better understand the broader implications of the syndrome. Methods: A total of 400 women participated: 200 with PCOS (Rotterdam criteria) and 200 age-matched controls. Data collected included body mass index (BMI), fasting glucose, lipid profiles, blood pressure, and inflammatory markers (CRP and IL-6). MetS was defined using NCEP ATP III criteria. Statistical analyses were performed to compare metabolic and cardiovascular markers between groups, with a significance level set at p < 0.05. Results: MetS prevalence was significantly higher in the PCOS group (60%) compared to controls (30%) (p < 0.01). Insulin resistance was greater in the PCOS group, with a mean HOMA-IR of 3.2 versus 1.8 in controls (p < 0.001), and fasting glucose levels were elevated (110 mg/dL vs. 95 mg/dL, p < 0.001). Lipid profiles were more atherogenic in PCOS, with higher triglycerides (150 mg/dL vs. 100 mg/dL, p < 0.01), higher LDL cholesterol (130 mg/dL vs. 110 mg/dL, p < 0.01), and lower HDL cholesterol (40 mg/dL vs. 50 mg/dL, p < 0.05). Blood pressure was also elevated in PCOS (systolic: 135 mm Hg vs. 120 mm Hg, p < 0.05; diastolic: 85 mm Hg vs. 75 mm Hg, p < 0.05). Inflammatory markers were significantly higher in PCOS, including CRP (4.2 mg/L vs. 2.1 mg/L) and IL-6 (6.0 pg/mL vs. 3.0 pg/mL) (both p < 0.01). Conclusion: Metabolic and cardiovascular risk factors are significantly more prevalent in women with PCOS. Early intervention, including management of insulin resistance, dyslipidemia, hypertension, and inflammation, is crucial to reducing cardiovascular morbidity and long-term health risks in this population.